STAAR Surgical Company
STAA
$18.03
$0.150.84%
NASDAQ
12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
---|---|---|---|---|---|
Net Income | -20.21M | 21.78M | 16.61M | 15.30M | 21.35M |
Total Depreciation and Amortization | 6.89M | 5.73M | 5.31M | 5.24M | 5.12M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 34.44M | 30.08M | 29.46M | 30.56M | 28.96M |
Change in Net Operating Assets | -5.40M | -10.53M | -14.12M | -9.73M | -40.84M |
Cash from Operations | 15.73M | 47.05M | 37.26M | 41.37M | 14.59M |
Capital Expenditure | -23.39M | -20.76M | -23.71M | -20.49M | -18.19M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -35.82M | 3.44M | 73.47M | 101.09M | 92.54M |
Cash from Investing | -59.22M | -17.32M | 49.76M | 80.60M | 74.35M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -165.00K | -164.00K | -161.00K | -159.00K | -161.00K |
Issuance of Common Stock | 7.39M | 7.76M | 13.36M | 14.47M | 9.67M |
Repurchase of Common Stock | -1.51M | -1.40M | -1.51M | -1.48M | -2.10M |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 5.72M | 6.20M | 11.69M | 12.83M | 7.42M |
Foreign Exchange rate Adjustments | -1.11M | 638.00K | -634.00K | -745.00K | 202.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -38.88M | 36.57M | 98.08M | 134.06M | 96.56M |